Thomas E. Mabry

Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain

Harry F. Dovey, Varghese John, J. P. Anderson et al. · Journal of Neurochemistry · 2001 · 879 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

The in vitro anti-hepatitis B virus activity of FIAU [1-(2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell

Kirk A. Staschke, Joseph M. Colacino, Thomas E. Mabry et al. · Antiviral Research · 1994 · 40 citations

Life Sciences, Biochemistry, Infectious Diseases +8

Glucocorticoid Receptor Modulators Informed by Crystallography Lead to a New Rationale for Receptor Selectivity, Function, and Implications for Structure-Based Design

Matthew W. Carson, J.G. Luz, Chen S. Suen et al. · Journal of Medicinal Chemistry · 2014 · 33 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

P4-339 Stereoselective inhibition of amyloid beta peptide secretion by LY450139, a novel functional gamma secretase inhibitor

Bruce D. Gitter, Dan L. Czilli, Weiying Li et al. · Neurobiology of Aging · 2004 · 29 citations

Life Sciences, Medicinal Chemistry, Pharmacology +16

Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects in MCF-7 cells of phenolic analogs of trioxifene, [3,4-dihydro-2-(4-methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl[methanone

Charles D. Jones, Larry C. Blaszczak, Tulio Suarez et al. · Journal of Medicinal Chemistry · 1992 · 28 citations · Full text

Medicine, Endocrinology, Pharmacology +5